OBJECTIVE: To determine awareness about human papillomavirus (HPV) among female students of medical field in Pakistan.
METHODS: A researcher administered, descriptive cross-sectional survey was conducted on a voluntary group of participants (n=629) belonging to medical field from August 2017 to December 2017. After taking permission from the administration random convenient sampling method was adopted. This survey included only female students who were currently studying in departments of medical/health sciences. Students of first and second professionals were excluded because they are beginners in medical fields.
RESULTS: The main source of information regarding HPV was academic curriculum (38.25%) of the respondents, with only 21.70% claiming that healthcare providers had educated them about the same. However, 70.11% also reported that HPV/Pap test had never been recommended by their doctors. Many participants 36.09% had no prior knowledge of HPV vaccines; while 56.28% were willing to get vaccinated, the remaining 23.21% claimed a variety of reasons for their unwillingness rest were uncertain. The top three reasons cited for unwillingness were being sexually inactive 54.79%, the reason of not knowing anything about vaccine 6.84% and cost of vaccines 6.84%.
CONCLUSION: This study established that despite having knowledge about HPV, the populace required sufficient information about HPV vaccination for its acceptance and to prevent and combat the disease.
KEY WORDS: Vaccination (MeSH); Papillomavirus Infections (MeSH); Papillomavirus Vaccines (MeSH); Uterine Cervical Neoplasms (MeSH); Human Papillomavirus (Non-MeSH); Awareness (MeSH); Students, Medical (MeSH); Students, Health Occupations (MeSH)
Azam, F, Shams-ul-Islam M, Prevention of human papilloma virus infection with vaccines. Prevention. J Pak Med Assoc 2010;60(8):676-81
Khan S, Jaffer NN, Khan MN, Rai MA, Shafiq M, Ali A, et al. Human papillomavirus subtype 16 is common in Pakistani women with cervical carcinoma. Int J Infect Dis 2007;11(4):313-7. DOI: 10.1016/j.ijid.2006.06.007.
Steben M, Duarte-Franco E. Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Onco 2007;107(2 Suppl 1):S2-5. DOI: 10.1016/j.ygyno.2007.07.067.
Badar, F, Anwar N, Meerza F, Sultan F. Cervical carcinoma in a Muslim community. Asian Pac J Cancer Prev 2007;8(1):24-6.
Siddiqa A, Zainab M, Qadri I, Bhatti MF, Parish JL. Prevalence and genotyping of high risk human papillomavirus in cervical cancer samples from Punjab, Pakistan. Viruses 2014;6(7):2762-77. DOI: 10.3390/v6072762
Bruni L, Barrionuevo-Rosas L, Albero G, Aldea M, Serrano B, Valencia S, et al. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report (Accessed: 12-01-2018)
Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010;202(12):1789-99. DOI: 10.1086/657321.
Do YK, Wong KY. Awareness and acceptability of human papillomavirus vaccine: an application of the instrumental variables bivariate probit model. BMC Public Health 2012;12:31. DOI:10.1186/1471-2458-12-31.
Downs LS, Scarinci I, Einstein MH, Collins Y, Flowers L. Overcoming the barriers to HPV vaccination in high-risk populations in the US. Gynecol Oncol 2010;117(3):486-90. DOI: 10.1016/j.ygyno.2010.02.011,
Singh GK, Miller BA, Hankey BF, Edwards BK. Persistent area socioeconomic disparities in US incidence of cervical cancer, mortality, stage, and survival, 1975–2000. Cancer 2004;101(5):1051-57. DOI: 10.1002/cncr.20467
Graham JE, Mishra A. Global challenges of implementing human papillomavirus vaccines. Int J Equity Health 2011;10:27. DOI: 10.1186/1475-9276-10-27
Medeiros LR, Rosa DD, Da-Rosa MI, Bozzetti MC, Zanini RR. Efficacy of human papillomavirus vaccines: a systematic quantitative review. Int J Gynecol Cancer 2009;19(7):1166-76. DOI: 10.1111/IGC.0b013e3181a3d100
Licht AS, Murphy JM, Hyland AJ, et al Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception? Sex Transm Infect 2010;86(1):74-8. DOI: 10.1136/sti.2009.037705
Dempsey A, Cohn L, Dalton V, Ruffin M. Worsening disparities in HPV vaccine utilization among 19–26 year old women. Vaccine 2011;29(3):528-34. DOI: 10.1016/j.vaccine.2010.10.051.
Limia A, Pachón I. Coverage of human papillomavirus vaccination during the first year of its introduction in Spain. Euro Surveill 2011;16(21): pii=19873. DOI: 10.2807/ese.16.21.19873-en
Rondy M, Van-Lier A, Van-de-Kassteele J, Rust L, De-Melker H. Determinants for HPV vaccine uptake in the Netherlands: A multilevel study. Vaccine 2010;28(9):2070-5. DOI: 10.1016/j.vaccine.2009.12.042.
Binagwaho A, Wagner CM, Gatera M, Karema C, Nutt CT, Ngaboa F. Achieving high coverage in Rwanda's national human papillomavirus vaccination programme. Bull World Health Organ 2012;90(8):623-8: DOI: 10.2471/BLT.11.097253.
Household Integrated Economic Survey (HIES) 2011-12. 2013, Pakistan Bureau of Statistics: Pakistan. http://www.pbs.gov.pk/content/household-integrated-economic-survey-hies-2015-16 (Accessed: 02-01-2018)
Drug Information System. www.druginfosys.com. (Accessed: 07-01-2018)
Pandey D, Vanya V, Bhagat S, Binu VS, Shetty J. Awareness and attitude towards human papillomavirus (HPV) vaccine among medical students in a premier medical school in India. PloS one 2012;7(7):e40619. DOI: 10.1371/journal.pone.0040619.
Hoque ME, Van Hal G. Acceptability of Human Papillomavirus Vaccine: A Survey among Master of Business Administration Students in KwaZulu-Natal, South Africa. Biomed Res Int. 2014;2014:257807. DOI: 10.1155/2014/257807
DiAngi YT, Panozzo CA, Ramogola-Masire D, Steenhoff AP, Brewer NT. A cross-sectional study of HPV vaccine acceptability in Gaborone, Botswana. PLoS One. 2011;6(10):e25481. DOI: 10.1371/journal.pone.0025481.
Joy T, Sathian B, Bhattarai C, Chacko J. Awareness of cervix cancer risk factors in educated youth: a cross-sectional, questionnaire based survey in India, Nepal, and Sri Lanka. Asian Pac J Cancer Prev 2011;12(7):1707-12.
Hopkins TG, Wood N. Female human papillomavirus (HPV) vaccination: global uptake and the impact of attitudes. Vaccine 2013;31(13):1673-9. DOI: 10.1016/j.vaccine.2013.01.028
McCaffery K, Forrest S, Waller J, Desai M, Szarewski A, Wardle J. Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African-Caribbean and white British women in the UK. Br J Cancer 2003. 88(1):42-6. DOI: 10.1038/sj.bjc.6600686
Jawaid A. Cervical cancer vaccine in Pakistan: let's start thinking. International Int J Infect Dis 2008;12(2):217. DOI: 10.1016/j.ijid.2007.04.014
Bharadwaj M, Hussain S, Nasare V, Das BC. HPV & HPV vaccination: issues in developing countries. Indian J Med Res 2009;130(3):327-33.
Bhatla N, Joseph E. Cervical cancer prevention & the role of human papillomavirus vaccines in India. Indian J Med Res 2009;130(3):334-40.